Skip to main content
Premium Trial:

Request an Annual Quote

AnaSpec, Geneva Bioinformatics

Premium
AnaSpec this week launched 15 new peptides for drug discovery research including Influenza Matrix Protein (62-70); MP (62-70); Cortistatin-29, human; and RSK3, Ribosomal S6 Kinase 3.
 

 
Geneva Bioinformatics has released a new version of its Phenyx protein identification software. Enhancements in Phenyx 2.5 include updated server-side code to accelerate searches; integration with the Institute for Systems Biology’s Trans Proteomics Pipeline and Proteome Software’s Scaffold; and improved web services that enable the integration of Phenyx into “any third-party proteomics pipeline.”
 
The company said it will be demonstrating the software at HUPO 2007 in Seoul, Korea, Oct. 6-10.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.